Merz has three subsidiaries Merz Pharmaceuticals, Merz Consumer Care and Merz Dental. Their beauty and wellness products are sold around the world under the brands of Merz Spezial (beauty care) and Tetesept (OTC drugs).

Research and development at Merz Pharmaceuticals in focused on neurological and psychiatric diseases, for example Alzheimer's dementia, Parkinson's disease and neuromuscular disturbances like dystonia and spasticity.

To maximise development and marketing opportunities, Merz work in partnership with Allergan Inc (USA) Forest Laboratories Inc (USA) Lundbeck (Denmark) Suntory Foundation/Daiichi Pharmaceuticals (Japan).

Products

Merz is a leader in Alzheimer's research and has developed the world's first drug for the treatment of moderate to severe stages of Alzheimer's diseases.

Axura - Alzheimer's

PK - Merz, PL - Levo- Parkinson's

Solvex - Depression

Mederma and Contractubex - Dermatology - scars

Imex - Dermatology - acne

Pantostin and Pantovigar - Dermatology - hair loss

Pilzcin and Naftin - Dermatology - fungal disease

Hyal System - Dermatology - wrinkles

Hepa - Merz - Liver disease

Lipo - Merz retard and Lipocol-Merz - Lipid metabolism disorders

Xeomin - Blepharospasm, Cervial Dystonia

www.merz.com

• Return to list